Celanese (CE)
(Delayed Data from NYSE)
$139.39 USD
-4.75 (-3.30%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $139.39 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Celanese Corporation [CE]
Reports for Purchase
Showing records 21 - 40 ( 471 total )
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
3Q23 First Look - EPS in Line as Demand/Pricing Still Challenged; FCF Stronger
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: 3Q23 Preview - Lack of Demand Recovery Is Starting to Be Priced In
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Upgrade to Overweight on Earnings Bottom; Self-Help Drives Healthy ''24 Growth
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
2Q23 Follow-Up - Terming Debt Out Would Derisk the Story Further, We Believe
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
2Q23 First Look - ''23 Guidance Cut Resets the 2H Bar
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: 2Q23 Preview - Demand Still Struggling; We Mostly Stick with Margin Stories
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department